Eptifibatide indications and usage: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 July 2014

5 February 2014

  • curprev 21:4521:45, 5 February 2014ShiSheng talk contribs 1,227 bytes +1,227 Created page with "__NOTOC__ {{Eptifibatide}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== ===Acute Coronary Syndrome (ACS)=== INTEGRILIN is indicated to decrease the rate of a combined e..."